An increasing concern in healthcare is the co-occurrence of mental and somatic disorders in patients, illustrated most prominently by the comorbidity of anxiety and mood disorders (AMD) with ...

Advances in genetic testing are improving the understanding of a variety of inherited cardiovascular diseases, but not all cardiologists are aware of the benefits and risks of incorporating genetic ...

• Cardiovascular disease (CVD) kills nearly 18 million people each year, more than all cancers combined1,2 • Elevated lipoprotein(a) or Lp(a), an inherited condition that raises CVD risk, affects 1 in ...

Cardiovascular diseases (CVD) cause about one in three deaths worldwide. The World Health Organization (WHO) estimates 19.8 million CVD deaths in 2022, roughly 32% of all deaths. Care remains reactive ...

Subtype-specific cardiovascular disease (CVD) associations are seen with Alzheimer's disease (AD), with the strongest, most ...

Over time, immune cells acquire mutations that promote atherosclerosis. Lifestyle changes may offset these DNA glitches, new ...

Understanding the aetiology of cardiovascular disease (CVD) remains a major research priority because CVD continues to be the leading cause of death globally. Coronary heart disease (CHD), which ...

People with lower interleukin-6 activity have a reduced risk of cardiovascular diseases, a new LMU study reveals. Lowering the activity of interleukin-6 (IL-6) – a key immune signal regulating ...

Among multiple cardiovascular disease subtypes examined in two large cohorts, hypotension shows the strongest association ...

The AHA recommends using whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases, which frequently manifest as life-threatening CV conditions. The American ...

Research revising lifespan heritability upward to 55% may affect how clinicians advise their patients about genetic risk and ...